Phthisis Diagnostics

Charlottesville, United States Founded: 2005 • Age: 21 yrs Acquired By Microbiologics
Molecular standards for infectious disease diagnostics are designed and manufactured.

About Phthisis Diagnostics

Phthisis Diagnostics is a company based in Charlottesville (United States) founded in 2005 was acquired by Microbiologics in October 2013.. Phthisis Diagnostics has raised $1.15 million across 7 funding rounds from investors including HHS, Afton Scientific and Microbiologics. Phthisis Diagnostics operates in a competitive market with competitors including Sino Biological, GenScript, Miltenyi Biotec, Manus Bio and Devyser, among others.

  • Headquarter Charlottesville, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.15 M (USD)

    in 7 rounds

  • Latest Funding Round
    $410 K (USD), Series A

    Jul 09, 2012

  • Investors
    HHS

    & 9 more

  • Employee Count
    Employee Count
  • Acquired by
    Microbiologics

    (Oct 22, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Phthisis Diagnostics

Phthisis Diagnostics has successfully raised a total of $1.15M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $410 thousand completed in July 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series A — $410,000
  • First Round

    (01 Aug 2008)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2012 Amount Series A - Phthisis Diagnostics Valuation Piedmont Angel Network
Apr, 2012 Amount Series A - Phthisis Diagnostics Valuation

investors

Apr, 2011 Amount Series A - Phthisis Diagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Phthisis Diagnostics

Phthisis Diagnostics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Afton Scientific and Microbiologics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage investments are provided to Mid-Atlantic startups by this group.
Founded Year Domain Location
Angel Network
Founded Year Domain Location
Family owned investment firm
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Phthisis Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Phthisis Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Phthisis Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Phthisis Diagnostics

Phthisis Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Miltenyi Biotec, Manus Bio and Devyser, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Develops tools and products for research and clinical application
domain founded_year HQ Location
Phytochemicals are developed using microbial fermentation processes.
domain founded_year HQ Location
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
domain founded_year HQ Location
The gut-brain axis is explored for therapeutic and nutritional innovations.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Phthisis Diagnostics

Frequently Asked Questions about Phthisis Diagnostics

When was Phthisis Diagnostics founded?

Phthisis Diagnostics was founded in 2005 and raised its 1st funding round 3 years after it was founded.

Where is Phthisis Diagnostics located?

Phthisis Diagnostics is headquartered in Charlottesville, United States. It is registered at Charlottesville, Virginia, United States.

Is Phthisis Diagnostics a funded company?

Phthisis Diagnostics is a funded company, having raised a total of $1.15M across 7 funding rounds to date. The company's 1st funding round was a Series A of $450K, raised on Aug 01, 2008.

What does Phthisis Diagnostics do?

Phthisis Diagnostics is now the molecular products division at Microbiologics. They have a patented process for designing and manufacturing molecular standards. These molecular standards are specifically designed to be used as performance controls for a wide variety of molecular instruments and assays in the pharmaceutical, food safety, and clinical testing. Helix Elite Molecular Standards are specifically designed and synthetically produced nucleic acids for use as a genetic surrogate for pathogens that are difficult to grow or that require specialized facilities or staff. Each standard contains consensus sequences of diagnostic regions from the targets genome and represents the known genetic diversity of the microorganism.

Who are the top competitors of Phthisis Diagnostics?

Phthisis Diagnostics's top competitors include Sino Biological, Manus Bio and Kallyope.

Who are Phthisis Diagnostics's investors?

Phthisis Diagnostics has 10 investors. Key investors include HHS, Afton Scientific, Microbiologics, Piedmont Investment Advisors, and Piedmont Angel Network.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available